Skip to main content
Log in

Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

This study evaluated the effect of inhaled volume and simulated inspiratory flow rate ramps on fine particle output from dry powder inhalers (DPIs). A simple, robust system was developed to account for “rate of rise” (ramp) effects while maintaining a constant air flow through a multi-stage liquid impinger (MSLI), used for sizing the emitted particles. Ramps were programmed to reach 30 and 60 L/min over 100 milliseconds; 500 milliseconds; and 1, 2, and 3 seconds. Rotahaler was chosen as the test DPI. Testing was done with simulated inhalation volumes of 2 L and 4 L. Testing was also carried out using the USP apparatus 4. At 30 L/min, for a 2 L volume, the amount of drug exiting the device in fine particle fraction (FPF) increased from 2.33 μg to 6.04 μg from the 3-second ramp to the 100-millisecond ramp, with 11.64 μg in FPF for the USP (no ramp) method. At the same flow rate, for a 4 L volume, FPF increased from 2.23 μg to 8.45 μg, with 10.25 μg for the USP method. At 60 L/min, similar trends were observed. In general, at both flow rates, an increase in FPF was noted going from the shallowest to the steepest ramp. However, there were no significant differences in FPF when a 2 L inhaled volume was compared with a 4 L volume at each flow rate. Overall, these data suggest that the existing USP apparatus may overestimate FPF at flow rates lower than those recommended by the USP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Crompton GK. Dry powder inhalers: advantages and limitations. J Aerosol Med. 1991;4(3):151–156.

    Article  CAS  Google Scholar 

  2. Dalby RN, Tiano SL. Medical devices for the delivery of therapeutic aerosols to the lung In: Hickey AJ, ed. Inhalation Aerosols: Physical and Biological Basis for Therapy. New York, NY: Marcel Dekker; 1996:441–473.

    Google Scholar 

  3. Ganderton D, Kassem NM. Dry powder inhalers. Adv Pharm Sci. 1992;6:165–191.

    CAS  Google Scholar 

  4. Kassem NM Ganderton D. The influence of carrier surface on the characteristics of inspirable powder aerosols. J Pharm Pharmacol. 1990;42:11P.

    Article  Google Scholar 

  5. Prime D., Atkins, P., Slater A. et al Review of dry powder inhalers. Advanced Drug Delivery Reviews. 1997;26:51–58.

    Article  CAS  Google Scholar 

  6. Newman SP, Johnson MA, Clarke SW. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma [letter]. Thorax. 1988;43(2):159.

    Article  CAS  PubMed Central  Google Scholar 

  7. Hickey J, Concessio N, Platz R. Factors influencing the dispersion of dry powders as aerosols. Pharm Tech. 1994;18:58–64.

    Google Scholar 

  8. United States Pharmacopeia. Physical tests and determinations, Section 601: Aerosols. Vol 24. Philadelphia, PA: National Publishing; 2000:1895–1912.

    Google Scholar 

  9. Byron PR. Compendial dry powder testing: USP perspectives. Respiratory Drug Delivery IV. Deerfield, IL: Interpharm Press; 1994:153–162.

    Google Scholar 

  10. Stimuli to the revision process. Pharmacopeial Forum. 1997;23(6):5216.

    Google Scholar 

  11. Chavan VS, Dalby RN. Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers. AAPS Pharm Sci. 2000;2(2), article 10; 1–7 Available at http://www.aapspharmsci.org/scientificjournals/pharmsci/journal/10.html

  12. Hickey AJ. Methods of aerosol particle size characterization. In: Hickey AJ, ed. Pharmaceutical Inhalation Aerosol Technology. Vol. 54, New York, NY: Marcel Dekker; 1992:219–255.

    Google Scholar 

  13. Washington C. Particle size analysis in inhalation metered dose inhaler technology. In: Purewal TS, Grant DJ, ed Metered Dose Inhaler Technology. Buffalo Grove, IL: Interpharm Press: 1998:177–145.

    Google Scholar 

  14. Miller NC, Olson BA, Marple VA. Measurement of the time required to reach steady state for air flow through some cascade impactors. Pharm Res. 1993;10(10):S165.

    Google Scholar 

  15. Webb J. In vitro testing of aerosols: what does the future hosd? J Aerosol Med. 1998;11(Suppl 1):S9-S10.

    Article  Google Scholar 

  16. Newman SP. How well do in vitro particle size measurements predict drug delivery in vivo? J Aerosol Med. 1998;11(Suppl 1):S97-S104.

    Article  Google Scholar 

  17. Staniforth JN. Particle interactions in dry powder formulation of aerocolloidal suspensions. In: Byron PR, ed Respiratory Drug Delivery II. Keystone, CO: Interpharm Press; 1990:531–542.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Published: April 11, 2002

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chavan, V., Dalby, R. Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler. AAPS PharmSci 4, 6 (2002). https://doi.org/10.1208/ps040211

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps040211

Key words

Navigation